Effects of intraluminal peptide YY on pancreatic function.
Peptide YY (PYY) is released postprandially into both the circulation and the distal intestinal lumen. While circulating PYY inhibits pancreatic secretion and insulin release, the effects of intraluminal PYY on pancreatic function are unknown. The aim of the present study was to evaluate the effect of exogenous, intraileal luminal PYY on pancreatic exocrine function and fasting glucose levels. Chronic pancreatic and ileal fistulae (50 cm from the ileocecal valve) were created in nine mongrel dogs. The animals were given intravenous infusions of secretin (125 ng/kg/h) and cholecystokinin octapeptide (CCK-8, 50 ng/kg/h) for four hours. At the beginning of the second hour, either normal saline or PYY, at low [physiologic (2 ng/min)] or high [supraphysiologic (50 ng/min)] levels, was infused antegrade into the ileal fistula for two hours. Pancreatic juice was collected for PYY and glucose levels. Ileal luminal PYY infusions had no effect on pancreatic bicarbonate or protein output. Fasting serum PYY and glucose concentrations were unaffected by either dose of intraluminal PYY. We conclude that ileal luminal PYY does not influence pancreatic exocrine function or fasting glucose levels.
Brodish
R J
RJ
Department of Surgery, University of Cincinnati School of Medicine, OH 45267.
Kuvshinoff
B W
BW
Fink
A S
AS
McFadden
D W
DW
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D004285:Dogs; D005768:Gastrointestinal Hormones / Q000097:blood / Q000494:pharmacology*; D010179:Pancreas / Q000187:drug effects* / Q000502:physiology; D019894:Peptide YY; D010455:Peptides / Q000097:blood / Q000494:pharmacology*; D012633:Secretin / Q000494:pharmacology; D012844:Sincalide / Q000494:pharmacology
D001786:Blood Glucose; D005768:Gastrointestinal Hormones; D010455:Peptides; D019894:Peptide YY; D012633:Secretin; D012844:Sincalide